Vivelle-Dot Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Vivelle-Dot
M
- M-Prednisolone (methylprednisolone)
- Macrobid (nitrofurantoin)
- Macrodantin (nitrofurantoin)
- magnesium citrate / melatonin
- Mandol (cefamandole)
- Marax (ephedrine / hydroxyzine / theophylline)
- Marax DF (ephedrine / hydroxyzine / theophylline)
- Margesic (acetaminophen / butalbital / caffeine)
- Marten-Tab (acetaminophen / butalbital)
- Matzim LA (diltiazem)
- mavacamten
- Maxaquin (lomefloxacin)
- Maxipime (cefepime)
- Me-PB-Hyos (atropine / hyoscyamine / phenobarbital / scopolamine)
- Mebaral (mephobarbital)
- Med-Jec-40 (methylprednisolone)
- Medicort (prednisolone)
- Medidex (dexamethasone)
- Medidex LA (dexamethasone)
- Medigesic (acetaminophen / butalbital / caffeine)
- Medipred (methylprednisolone)
- Medralone (methylprednisolone)
- Medralone 40 (methylprednisolone)
- Medralone 80 (methylprednisolone)
- Medrol (methylprednisolone)
- Medrol Dosepak (methylprednisolone)
- Mefoxin (cefoxitin)
- Mega-C-Acid Plus (ascorbic acid)
- melatonin
- Melatonin Sleep Time Release (melatonin / pyridoxine)
- Melatonin Time Release (melatonin)
- melatonin / pyridoxine
- melatonin / turmeric
- mephobarbital
- meropenem
- meropenem / vaborbactam
- Merrem (meropenem)
- Merrem Novaplus (meropenem)
- Metaglip (glipizide / metformin)
- metformin
- metformin / pioglitazone
- metformin / repaglinide
- metformin / rosiglitazone
- metformin / saxagliptin
- metformin / sitagliptin
- Methacort 40 (methylprednisolone)
- Methacort 80 (methylprednisolone)
- methicillin
- Methylcotol (methylprednisolone)
- Methylcotolone (methylprednisolone)
- Methylpred DP (methylprednisolone)
- methylprednisolone
- MethylPREDNISolone Dose Pack (methylprednisolone)
- Meticorten (prednisone)
- Metopirone (metyrapone)
- Metro (metronidazole)
- Metro IV (metronidazole)
- metronidazole
- Metryl (metronidazole)
- metyrapone
- Mezlin (mezlocillin)
- mezlocillin
- mibefradil
- Micomp-PB (belladonna / caffeine / ergotamine / pentobarbital)
- miconazole
- Micronase (glyburide)
- Mifeprex (mifepristone)
- mifepristone
- miglitol
- Migracet-PB (belladonna / caffeine / ergotamine / pentobarbital)
- Millipred (prednisolone)
- Millipred DP (prednisolone)
- Minocin (minocycline)
- Minocin for Injection (minocycline)
- minocycline
- Minolira (minocycline)
- Minotal (acetaminophen / butalbital / caffeine)
- Miradon (anisindione)
- mitotane
- MLK F2 (bupivacaine / lidocaine / triamcinolone)
- mobocertinib
- modafinil
- momelotinib
- Mondoxyne NL (doxycycline)
- Monocid (cefonicid)
- Monodox (doxycycline)
- Morgidox (doxycycline)
- Mounjaro (tirzepatide)
- Moxatag (amoxicillin)
- moxifloxacin
- moxifloxacin / triamcinolone
- moxifloxacin / triamcinolone ophthalmic
- Moxilin (amoxicillin)
- Mudrane (aminophylline / ephedrine / phenobarbital / potassium iodide)
- Mudrane GG (aminophylline / ephedrine / guaifenesin / phenobarbital)
- Mudrane GG-2 (aminophylline / guaifenesin)
- Multaq (dronedarone)
- MY-E (erythromycin)
- Mycelex Troche (clotrimazole)
- Mycifradin (neomycin)
- Mycobutin (rifabutin)
- Mygracet (acetaminophen / butalbital / caffeine)
- Myrac (minocycline)
- Mysoline (primidone)
- Myxredlin (insulin regular)
More about Vivelle-Dot (estradiol)
- Vivelle-Dot consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (37)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: estrogens
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.